Tsung-Hui Hu
Chang Gung Memorial Hospital, Kaohsiung, Taiwan
- Professor of Kaohsiung Chang Gung Memorial Hospital
- Research primarily focuses on hepatocellular carcinoma (HCC) and gastrointestinal stromal tumors (GIST).
- Considered a pioneer in the study of the PTEN-AKT signaling pathway in liver cancers in Taiwan.
- Significant contributions to understanding the molecular basis of GIST in Taiwan.
- Interests also encompass the treatment of hepatitis B and C, as well as antiviral therapies post-liver transplantation.
- Has established predictive models for HCC development after antiviral therapies, particularly for individuals with sustained virological response.
- Explores the impact of antiviral therapies such as telbivudine, entecavir, and tenofovir on kidney function.
- Actively involved in community-based HCC screening and hepatitis C micro-elimination efforts in Changhua County, Taiwan.
- Boasts a substantial publication record, including 288 academic papers in peer-reviewed journals and 68 papers as the first or corresponding author, in addition to one book chapter.
- Has served as the principal investigator for 36 research grants and 34 clinical trial programs.
